Who is sponsoring NCT06895122?

NCT06895122 is sponsored by University of Salamanca.

What drugs are being tested in NCT06895122?

Interventions in NCT06895122: High resistance training, Multicomponent Training.

What condition does NCT06895122 study?

NCT06895122 studies Sarcopenic Obesity, Obesity and Overweight, Sarcopenia.

Is NCT06895122 still recruiting?

NCT06895122 is currently completed. Last updated 30 March 2025.

Last reviewed 2025-03-30 · How we verify

NCT06895122

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effectiveness of Different Types of Training in Older Adults With Sarcopenic Obesity

Completed NA Last updated 30 March 2025

What this trial tests

NA trial testing High resistance training in Sarcopenic Obesity in 33 participants. Completed in 31 December 2024.

Timeline

1 September 2022

Primary endpoint
31 December 2023

31 December 2024

Quick facts

Lead sponsor	University of Salamanca
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	33
Start date	1 September 2022
Primary completion	31 December 2023
Estimated completion	31 December 2024
Sites	1 location across Spain

Drugs / interventions tested

High resistance training
Multicomponent Training

Conditions studied

Sarcopenic Obesity — all drugs for Sarcopenic Obesity →
Obesity and Overweight — all drugs for Obesity and Overweight →
Sarcopenia — all drugs for Sarcopenia →

Sponsor

University of Salamanca

Who can join

65 and older, female only, with Sarcopenic Obesity or Obesity and Overweight. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is a randomized, parallel-group, double-blind clinical trial. The primary aim is to assess the effectiveness of power-based resistance training, multimodal exercise incorporating non-specific movements, and a control group in improving functionality and body composition in women over 65 years old with pre-sarcopenia. The intervention will take place over 30 weeks, with three training sessions per week in both experimental groups. Assessments will be conducted at two time points: before and after the intervention. Evaluated parameters will include functionality (Timed Up \& Go test (TUG), chair stand test, handgrip strength, and Short Physical Performance Battery (SPPB)) and body composition (body fat percentage, skeletal muscle index (SMI), appendicular skeletal muscle mass (ASM), waist circumference, waist-to-hip ratio, body weight, and body mass index (BMI)).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Efficacy of Power Training on Sarcopenic Obesity in Community-Dwelling Older Women: A 32-Week Randomized Clinical Trial.
Polo-Ferrero L, Martin MJ, Puente-González AS, Barbero-Iglesias FJ, et al · · 2025 · cited 2× · PMID 40507091 · DOI 10.3390/nu17111822

Verify or expand the search:

Other recruiting trials for Sarcopenic Obesity

Currently open trials in the same condition.

NCT07154719 — GLP-1R Actions on Muscle and the Skeleton · Phase 4 · recruiting
NCT07035483 — Changes in Fat and Muscle Tissue Function and Their Impact on Metabolic Health After Bariatric Surgery · active not recruiting
NCT06600581 — Safety and Efficacy of IMM01-STEM Against Placebo on Muscle Performance in Seniors With Obesity and Muscle Weakness · Phase 2 · active not recruiting
NCT06826963 — Feasibility and Effectiveness of Eccentric Exercise in Sarcopenic Older Adults with Heart Failure: a Pilot Study · NA · recruiting
NCT06822504 — Prevalence of Sarcopenic Obesity in COPD · recruiting

Other University of Salamanca trials

Trials by the same sponsor.

NCT07359495 — Multicomponent Training and Muscle Quality in Older Women · NA · not yet recruiting
NCT07286539 — Precision Physical Exercise for Personalized Onco-Hematology. · NA · not yet recruiting
NCT07387770 — Muscle Deterioration in Hospitalized Cancer Patient · NA · not yet recruiting
NCT07387757 — Exergames in Mental Health · NA · not yet recruiting
NCT07333768 — EQUISOCK: New Antiequine · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06895122 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Salamanca
Last refreshed: 30 March 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06895122.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing